Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac

• Status: Completed
• Trial end date: 2022-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to compare two groups of post-orthopedic patients who received a standard regimen, namely ketorolac 30mg, to the second group, which was given the standard regimen and adjuvant magnesium sulfate 30mg/kgBW 1 hour preoperatively. If it is proven useful, it is hoped that pain will be more controlled, reduce pain complications, reduce treatment costs, and reduce the duration of hospital stays.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Indonesia University

Criteria

Inclusion Criteria:

• Patients undergoing lower extremity orthopedic surgery under general anaesthesia.

• Patients aged 18-60 years.

• Physical status ASA 1-3

• Willing to participate in research.

Exclusion Criteria:

• Patients who are hemodynamically unstable.

• Patients with decreased renal function

• Patients with skeletal muscle disorders.

• Patients with Ketorolac allergy

• Patients with morphine allergy